Study Information

What’s involved?

  • 2 days & nights inpatient stay
  • 11 quick follow-up appointments

This clinical trial has been approved by an independent ethics committee.

About the study

We need healthy males for a medication comparison study.

This study is looking at a medication for the potential treatment for paroxysmal nocturnal haemoglobinuria (PNH). This is a rare disorder that causes red blood cells to break down sooner than they should. This is a biosimilar study. This means that the medication being tested is an almost identical version of a medication that has already been approved called Soliris®.

At this stage of testing we are not looking at whether it will have any therapeutic value, so we require healthy males to participate.

How do I find out more?

If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at reply@clinicalstudies.com.au quoting “Similar Study”.

If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!

  • 2
    Nights Inpatient Stay
  • 11
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy Males Only
  • Aged 18 – 45 years old
  • Body Mass Index (BMI) 18 - 30kg/m²
  • Weight 50kg - 90kg
  • Non-smokers, social smokers or smokers of up to 10 per day
Top